Condition
Influenza A Infection
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Enrolling By Invitation1
Terminated1
Clinical Trials (2)
Showing 2 of 2 trials
NCT06401720Enrolling By InvitationPrimary
Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection
NCT00830323Phase 2TerminatedPrimary
Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection
Showing all 2 trials